Evidence map›Paper›PMID 30237436›Full record

ArticleScientific reports2018

Acylated-acyl carrier protein stabilizes the Pseudomonas aeruginosa WaaP lipopolysaccharide heptose kinase.

Naomi N K Kreamer, Rajiv Chopra, Ruth E Caughlan, Doriano Fabbro, Eric Fang, Patricia Gee, Ian Hunt, Min Li, Barbara C Leon, Lionel Muller and 5 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 2 countries.

Naomi N K KreamerInfectious Diseases, Novartis Institutes for Biomedical Research, Emeryville, CA, USA.
Rajiv ChopraChemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Cambridge, MA, USA. rajiv.chopra@novartis.com.
Ruth E CaughlanInfectious Diseases, Novartis Institutes for Biomedical Research, Emeryville, CA, USA.
Doriano FabbroChemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Basel, Switzerland.
Eric FangInfectious Diseases, Novartis Institutes for Biomedical Research, Emeryville, CA, USA.
Patricia GeeChemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Cambridge, MA, USA.
Ian HuntChemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Cambridge, MA, USA.
Min LiInfectious Diseases, Novartis Institutes for Biomedical Research, Emeryville, CA, USA.
Barbara C LeonInfectious Diseases, Novartis Institutes for Biomedical Research, Emeryville, CA, USA.
Lionel MullerChemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Basel, Switzerland.
Brian VashChemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Cambridge, MA, USA.
Angela L WoodsInfectious Diseases, Novartis Institutes for Biomedical Research, Emeryville, CA, USA.
Travis StamsChemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Cambridge, MA, USA.
Charles R DeanInfectious Diseases, Novartis Institutes for Biomedical Research, Emeryville, CA, USA.
Tsuyoshi UeharaInfectious Diseases, Novartis Institutes for Biomedical Research, Emeryville, CA, USA. tsuyoshi.uehara@gmail.com.
Novartis (United States) · USNovartis Institutes for BioMedical ResearchNovartis (Switzerland) · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Phosphorylation of Pseudomonas aeruginosa lipopolysaccharide (LPS) is important for maintaining outer membrane integrity and intrinsic antibiotic resistance. We solved the crystal structure of the LPS heptose kinase WaaP, which is essential for growth of P. aeruginosa. WaaP was structurally similar to eukaryotic protein kinases and, intriguingly, was complexed with acylated-acyl carrier protein (acyl-ACP). WaaP produced by in vitro transcription-translation was insoluble unless acyl-ACP was present. WaaP variants designed to perturb the acyl-ACP interaction were less stable in cells and exhibited reduced kinase function. Mass spectrometry identified myristyl-ACP as the likely physiological binding partner for WaaP in P. aeruginosa. Together, these results demonstrate that acyl-ACP is required for WaaP protein solubility and kinase function. To the best of our knowledge, this is the first report describing acyl-ACP in the role of a cofactor necessary for the production and stability of a protein partner.

Indexed as

AcylationAcyl Carrier ProteinBacterial ProteinsLipopolysaccharidesPseudomonas aeruginosaAcyl Carrier ProteinBacterial ProteinsLipopolysaccharides

Identifiers

PMID30237436
PMCPMC6147952
OpenAlexW2891229148

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.